← SynDRA
SYN1821566
SynDRA canonical compound SYN1821566 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PTPN11 |
|---|
| Mechanism of action | protein tyrosine kinase inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- RefChem:913770
- SHP099
- SHP 099
- MFCD29059453
- 5OD
- SHP099 free base
- SHP099 free base?
- SHP099 2HCl
- SHP-099 2HCl
- orb1304056
- SCHEMBL16914284
- SCHEMBL29352400
- BDBM38019
- CHEBI:234265
- US10093646, Compound 1
- BXC74742
- EX-A1067
- NSC804254
- s6388
- AKOS030526670
- CS-5684
- NSC-804254
- SB18819
- AC-35665
- BS-16291
- SY251378
- DB-107836
- HY-100388
- T3564
- EN300-21637536
- F544411
- 6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3-bis(chloranyl)phenyl]pyrazin-2-amine
Look up SYN1821566 in the interactive SynDRA portal →